Vertiv (NYSE:VRT) Price Target Raised to $151.00
Oppenheimer boosted their price target on shares of Vertiv from $140.00 to $151.00 and gave the stock an “outperform” rating in a research report on Thursday.
Source link
Similar Posts
Zydus Lifesciences Shares Plunge 3% Despite Receiving USFDA Approval – Equitypandit
Shares of Zydus Lifesciences Ltd were trading 3% lower on 22 May despite the company receiving final approval from the US health authorities to produce and sell 300 mg and 450 mg doses of Theophylline Extended-Release Tablets. The business informed the stock exchanges that the tablets can be used to treat COPD, also known as chronic…
Hilton drops Minneapolis hotel over cancelled ICE bookings
Hilton drops Minneapolis hotel over cancelled ICE bookings Source link
War, money, oil and the shaping of Aramco’s giant share sale
As the boss of the world’s biggest oil company flew around the world in early June to drum up investor interest in one of the biggest share sales in recent years, he could breathe a sigh of relief. Five years after Aramco’s $29.4 billion listing had been marred by temper tantrums and U-turns that left…
Understanding Treasury Bonds: Are They Right for Your Portfolio?
Treasury bonds are the cornerstone of many investment portfolios, offering investors a safe and reliable way to invest in the U.S. government. These long-term debt securities are backed by the full faith and credit of the U.S. government, making them one of the most secure investment options available. Treasury bonds offer fixed interest payments, known…
